医学
镇静
瑞芬太尼
麻醉
气管插管
右美托咪定
气道
重症监护医学
插管
加药
利多卡因
气管导管
指南
咪唑安定
喉镜检查
养生
气道管理
支气管痉挛
药效学
支气管镜检查
金标准(测试)
镇静剂
作者
Daniele Salvatore Paternò,Luigi La Via,Emilia Concetta Lo Giudice,Massimiliano Sorbello
标识
DOI:10.1097/aco.0000000000001670
摘要
PURPOSE OF REVIEW: This review synthesizes current evidence on pharmacological strategies for awake tracheal intubation (ATI), a cornerstone technique for anticipated difficult airways that remains underutilized despite guideline recommendations. RECENT FINDINGS: Over 30 sedation regimens have been described, with no single protocol demonstrating clear superiority. Dexmedetomidine shows the most complete pharmacological profile, providing anxiolysis, antisialagogue effects, and cough suppression with minimal respiratory depression. Ultra-short-acting agents such as remifentanil and remimazolam enable precise titration via target-controlled infusion. Combination regimens reduce individual drug dosing and associated side effects. Lidocaine remains the gold standard for topicalization (maximum 9 mg/kg lean body weight), with various administration routes showing equivalent efficacy when properly applied. Emerging evidence supports videolaryngoscopy as an alternative to flexible bronchoscopy for selected cases. SUMMARY: Successful ATI depends on adequate airway topicalization, judicious sedation maintaining spontaneous ventilation, and operator expertise. Any sedation regimen proves superior to none, but meticulous dose titration and monitoring are essential. Standardized training and institutional protocols remain critical for optimizing safety and utilization.
科研通智能强力驱动
Strongly Powered by AbleSci AI